decreased susceptibility to hepatic steatosis_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>

http://metadb.riken.jp/0002310B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw

decreased susceptibility to hepatic steatosis_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• sphingomyelin synthase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1921692

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sgms2<tm1Kenw>/Sgms2<tm1Kenw>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sgms2<tm1Kenw>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129S2-Sgms2<tm1Kenw>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased susceptibility to hepatic steatosis
  http://purl.obolibrary.org/obo/MP_0002310

文献

http://purl.org/net/cito/citesAsAuthority

• Susumu. Mitsutake, et.al., Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes., The Journal of biological chemistry, 2011, 286
  http://rdf.ncbi.nlm.nih.gov/pubmed/21669879